Meridian Bioscience: Q2 Earnings Insights

Meridian Bioscience VIVO reported its Q2 earnings results on Friday, May 6, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Meridian Bioscience beat estimated earnings by 40.43%, reporting an EPS of $0.66 versus an estimate of $0.47.

Revenue was up $25.97 million from the same period last year.

Last quarter the company beat on EPS by $0.1 which was followed by a 12.16% increase in the share price the next day.

Here's a look at Meridian Bioscience's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	0.25	0.20	0.31	0.48
EPS Actual	0.35	0.23	0.22	0.56
Revenue Estimate	70.29M	68.40M	77.22M	84.48M
Revenue Actual	88.34M	76.20M	63.51M	85.26M

To track all earnings releases for Meridian Bioscience visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.